Physician profile
Christopher Taylor Smith
NPI 1013438977
$1,146.78
in general payments reported to CMS, 2019-2025
16 companies · $11.41 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.46 · 2020: $58.59 · 2021: $391 · 2022: $427 · 2023: $183 · 2025: $11.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $230.09 | 2020-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $177.66 | 2019-2022 | |
| Pfizer INC. | $177.18 | 2021-2022 | |
| Grifols USA, LLC | $132.43 | 2022-2023 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $88.19 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $67.57 | 2021-2023 | Verquvo, Belsomra |
| Boston Scientific Corporation | $63.46 | 2021-2022 | |
| Intuitive Surgical, INC. | $54.50 | 2022 | |
| Novo Nordisk INC | $50.00 | 2019 | |
| Abbott Laboratories | $19.96 | 2023 | Diamondback Coronary |
| Mylan Specialty L.P. | $18.81 | 2023 | Yupelri |
| Chiesi USA, INC. | $15.46 | 2022 | |
| Kls-Martin L.P. | $13.89 | 2022 | |
| Daxor Corporation | $13.53 | 2023 | Bva-100 |
| Allergan, INC. | $12.64 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.41 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.